Keynote 695 clinical trial still open: Intratumoral plus Pembro

[missyrand]

clinicaltrials.gov/ct2/show...

This study looks at injecting tumors with Tavo while also on Pembro (Keytruda). You have to have tumors of a certain size that are easily accessible for the most part to be eligible for this study (for instance, lung tumors are not eligible locations). Theory is if you can trick the tumors into fighting the melanoma, they will then share this information with other cells who will spread the news throughout the body. Must have Stage 3-4 melanoma.

Passing this along.

Missy